Skip to main content

Table 6 ANOVA for the quadratic model {cumulative amount of drug permeated in 24 h (Q24) response}

From: Development, optimization and characterization of flurbiprofen matrix transdermal drug delivery system using Box–Behnken statistical design

Source

Sum of squares

df

Mean square

F value

p value

 

Model

1.198E+07

9

1.331E+06

29.86

< 0.0001

Significant

A-HPMC K15M:ERL100

2.175E+06

1

2.175E+06

48.80

0.0002

 

B-Di-butyl pthalate

41075.66

1

41075.66

0.9214

0.3691

 

C-d-limonene

9.490E+06

1

9.490E+06

212.88

< 0.0001

 

AB

13157.35

1

13157.35

0.2952

0.6038

 

AC

1.602E+05

1

1.602E+05

3.59

0.0999

 

BC

506.30

1

506.30

0.0114

0.9181

 

A2

4649.90

1

4649.90

0.1043

0.7562

 

B2

21226.92

1

21226.92

0.4762

0.5124

 

C2

65378.56

1

65378.56

1.47

0.2652

 

Residual

3.120E+05

7

44577.82

   

 Lack of Fit

86074.35

3

28691.45

0.5079

0.6978

Not significant

 Pure error

2.260E+05

4

56492.60

   

Cor total

1.229E+07

16